✦ LIBER ✦

Novel 4,4-bis(trifluoromethyl) imidazolines as stereospecific and orally active acyl coa: Cholesterol acyltransferase (ACAT) inhibitors and antihypercholesterolemic agents

✍ Scribed by George A Boswell; Hui-Yin Li; Indawati Delucca; Jeffrey T. Billheimer; Spencer Drummond; Peter J. Gillies; Candy Robinson

Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 216 KB
Volume: 6
Category: Article
ISSN: 0960-894X
DOI: 10.1016/0960-894x(96)00137-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Inhibitors of Acyl-

ChemInform Abstract: Inhibitors of Acyl-CoA:Cholesterol O-Acyltransferase (ACAT) as Hypocholesterolemic Agents: Synthesis and Structure—Activity Relationships of Novel Series of Sulfonamides, Acylphosphonamides and Acylphosphoramidates.

✍ H. T. LEE; W. H. ROARK; J. A. PICARD; D. R. SLISKOVIC; B. D. ROTH; R. L. STANFIE 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 32 KB 👁 2 views

ChemInform Abstract: Discovery of a Pote

ChemInform Abstract: Discovery of a Potent and Orally Available Acyl-CoA: Cholesterol Acyltransferase Inhibitor as an Antiatherosclerotic Agent: (4-Phenylcoumarin)acetanilide Derivatives.

✍ Masaki Ogino; et al. et al. 📂 Article 📅 2012 🏛 John Wiley and Sons ⚖ 21 KB 👁 1 views

## Abstract Structure‐activity relationship studies lead to the discovery of compound (I), which shows potent ACAT inhibitory activity (IC~50~ = 12 nM) and good pharmacokinetic profile in mice.